ID   ANTA_HAEOF              Reviewed;         136 AA.
AC   P15358; Q9TWQ8; Q9TX45;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 2.
DT   07-APR-2021, entry version 112.
DE   RecName: Full=Antistasin;
DE            Short=ATS;
DE   AltName: Full=Blood coagulation factor Xa/proclotting enzyme inhibitor;
DE   Flags: Precursor;
OS   Haementeria officinalis (Mexican leech).
OC   Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Annelida; Clitellata;
OC   Hirudinea; Hirudinida; Glossiphoniiformes; Glossiphoniidae; Haementeria.
OX   NCBI_TaxID=6410;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2470652; DOI=10.1016/0378-1119(89)90382-x;
RA   Han J.H., Law S.W., Keller P.M., Kniskern P.J., Silberklang M., Tung J.S.,
RA   Gasic T.B., Gasic G.J., Friedman P.A., Ellis R.W.;
RT   "Cloning and expression of cDNA encoding antistasin, a leech-derived
RT   protein having anti-coagulant and anti-metastatic properties.";
RL   Gene 75:47-57(1989).
RN   [2]
RP   PROTEIN SEQUENCE OF 18-136, AND PYROGLUTAMATE FORMATION AT GLN-18.
RC   TISSUE=Saliva;
RX   PubMed=3164720;
RA   Nutt E., Gasic T., Rodkey J., Gasic G.J., Jacobs J.W., Friedman P.A.,
RA   Simpson E.;
RT   "The amino acid sequence of antistasin. A potent inhibitor of factor Xa
RT   reveals a repeated internal structure.";
RL   J. Biol. Chem. 263:10162-10167(1988).
RN   [3]
RP   PROTEIN SEQUENCE OF 18-136.
RC   TISSUE=Saliva;
RX   PubMed=8271959; DOI=10.1016/0076-6879(93)23052-o;
RA   Dunwiddie C.T., Waxman L., Vlasuk G.P., Friedman P.A.;
RT   "Purification and characterization of inhibitors of blood coagulation
RT   factor Xa from hematophagous organisms.";
RL   Methods Enzymol. 223:291-312(1993).
RN   [4]
RP   REACTIVE SITE.
RX   PubMed=2777803;
RA   Dunwiddie C., Thornberry N.A., Bull H.G., Sardana M., Friedman P.A.,
RA   Jacobs J.W., Simpson E.;
RT   "Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of
RT   enzyme inhibition and identification of the reactive site.";
RL   J. Biol. Chem. 264:16694-16699(1989).
RN   [5]
RP   SULFATIDE-BINDING.
RX   PubMed=2745433;
RA   Holt G.D., Krivan H.C., Gasic G.J., Ginsburg V.;
RT   "Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide
RT   (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins
RT   that bind sulfated glycoconjugates.";
RL   J. Biol. Chem. 264:12138-12140(1989).
RN   [6]
RP   MUTAGENESIS.
RX   PubMed=1445252; DOI=10.1042/bj2870943;
RA   Hofmann K.J., Nutt E.M., Dunwiddie C.;
RT   "Site-directed mutagenesis of the leech-derived factor Xa inhibitor
RT   antistasin. Probing of the reactive site.";
RL   Biochem. J. 287:943-949(1992).
RN   [7]
RP   MUTAGENESIS.
RX   PubMed=8073407; DOI=10.1016/0049-3848(94)90138-4;
RA   Theunissen H.J., Dijkema R., Swinkels J.C., de Poorter T.L., Vink P.M.,
RA   van Dinther T.G.;
RT   "Mutational analysis of antistasin, an inhibitor of blood coagulation
RT   factor Xa derived from the Mexican leech Haementeria officinalis.";
RL   Thromb. Res. 75:41-50(1994).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 24-127.
RX   PubMed=9311976; DOI=10.1093/emboj/16.17.5151;
RA   Lapatto R., Krengel U., Schreuder H.A., Arkema A., de Boer B., Kalk K.H.,
RA   Hol W.G.J., Grootenhuis P.D.J., Mulders J.W.M., Dijkema R.,
RA   Theunissen H.J.M., Dijkstra B.W.;
RT   "X-ray structure of antistasin at 1.9-A resolution and its modelled complex
RT   with blood coagulation factor Xa.";
RL   EMBO J. 16:5151-5161(1997).
CC   -!- FUNCTION: This highly disulfide-bonded protein is a potent inhibitor of
CC       factor Xa. May have therapeutic utility as an anticoagulant. Also
CC       exhibits a strong metastatic activity.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- MISCELLANEOUS: Binds to heparin-agarose, binds to sulfated
CC       glycoconjugates.
CC   -!- MISCELLANEOUS: At least four isoforms of antistasin have been
CC       identified in leech salivary gland extracts, which differ by 1 or 2
CC       amino-acid residues.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I15 (antistasin) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M24422; AAA29192.1; -; mRNA.
DR   EMBL; M24423; AAA29193.1; -; mRNA.
DR   PIR; A28806; A28806.
DR   PIR; A34398; A34398.
DR   PIR; JS0209; JS0209.
DR   PIR; S13904; S13904.
DR   PDB; 1SKZ; X-ray; 1.90 A; A=20-136.
DR   PDBsum; 1SKZ; -.
DR   SMR; P15358; -.
DR   MEROPS; I15.007; -.
DR   EvolutionaryTrace; P15358; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0050819; P:negative regulation of coagulation; IEA:InterPro.
DR   InterPro; IPR004094; Antistasin-like.
DR   InterPro; IPR011061; Hirudin/antistatin.
DR   InterPro; IPR008086; Prot_inh_I15_antistasin_leech.
DR   Pfam; PF02822; Antistasin; 1.
DR   PRINTS; PR01706; ANTISTASIN.
DR   SUPFAM; SSF57262; SSF57262; 2.
DR   PROSITE; PS51252; ANTISTASIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Blood coagulation; Direct protein sequencing; Disulfide bond;
KW   Hemostasis; Heparin-binding; Protease inhibitor;
KW   Pyrrolidone carboxylic acid; Repeat; Secreted; Serine protease inhibitor;
KW   Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000269|PubMed:3164720,
FT                   ECO:0000269|PubMed:8271959"
FT   CHAIN           18..136
FT                   /note="Antistasin"
FT                   /id="PRO_0000001700"
FT   DOMAIN          45..70
FT                   /note="Antistasin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00582"
FT   DOMAIN          100..125
FT                   /note="Antistasin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00582"
FT   REGION          114..117
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          128..135
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000255"
FT   SITE            51..52
FT                   /note="Reactive bond"
FT   SITE            106..107
FT                   /note="Reactive bond"
FT   MOD_RES         18
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:3164720"
FT   DISULFID        25..36
FT   DISULFID        30..43
FT   DISULFID        45..65
FT   DISULFID        50..68
FT   DISULFID        54..70
FT   DISULFID        79..90
FT   DISULFID        84..97
FT   DISULFID        99..120
FT   DISULFID        105..123
FT   DISULFID        109..125
FT   VARIANT         22
FT                   /note="G -> R (in isoform B)"
FT   VARIANT         47
FT                   /note="G -> E"
FT   VARIANT         52
FT                   /note="M -> V"
FT   VARIANT         71
FT                   /note="R -> I"
FT   HELIX           25..28
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   TURN            38..40
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          58..60
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          66..70
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   HELIX           81..83
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   TURN            92..94
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          95..97
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          99..101
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          113..115
FT                   /evidence="ECO:0007744|PDB:1SKZ"
FT   STRAND          121..125
FT                   /evidence="ECO:0007744|PDB:1SKZ"
SQ   SEQUENCE   136 AA;  15225 MW;  582AF009ED9A0291 CRC64;
     MIKLAILLLF TVAIVRCQGP FGPGCEEAGC PEGSACNIIT DRCTCSGVRC RMHCPHGFQR
     SRYGCEFCKC RLEPMKATCD ISECPEGMMC SRLTNKCDCK IDINCRKTCP NGLKRDKLGC
     EYCECRPKRK LIPRLS
//
